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Abstract 
 
Reactive oxygen species (ROS) are emerging as regulators of protein redox states which 
influence many physiological processes. Current methods for the detection of protein redox 
states, including mass spectrometry, are expensive and not easily accessible or poorly validated. 
IRdye800CW Maleimide, a highly sensitive maleimide-based infrared dye, has been reported to 
detect the redox state of immunoprecipitated proteins in cardiac muscle using modified western 
blot procedures, but has yet to be validated as a novel tool to detect redox conditions throughout 
the proteome using common and cost-effective assays. In this study we tested the efficacy of 
IRDye800CW Maleimide in detecting protein redox state in cardiac muscle using mini-gel SDS-
PAGE and an in-well approach. Chemical and heat-induced modifications to cardiac tissue redox 
states were accurately detected with the dye in cardiac lysates. These findings were also validated 
against HPLC measures of GSSG content. 
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Chapter 1: Introduction 
 
As Earth’s atmosphere became increasingly oxidizing over millions of years, organisms 
acquired specific biological systems to help deal with this change. This highly conserved 
reduction-oxidation (redox) system has evolved in order to help maintain homeostasis within 
living organisms to protect against the potentially toxic oxidizing atmosphere through many 
redox sensitive components in mammals and plants (See table 1). Indeed, it has been established 
that over-exposure to oxidants beyond the protective limits of the cells can lead to protein 
dysfunction and cell death
1–5
. Over the last 20 years, however, research has extended the role of 
redox systems and oxidants to include regulation of many physiological processes. This form of 
regulation is termed ‘redox signaling’ and has been implicated in the regulation of many cellular 
processes including metabolism, transcription, inflammation and cell proliferation
6,7
. 
The ability of redox-sensitive molecules to alternate between the reduced and oxidized state is 
what prompts much of the signaling processes to occur. A molecule is said to be in the reduced 
state when it has gained one or more electrons while an oxidized molecule is one that has lost 
one or more electrons. The key compound in redox biology that is capable of undergoing these 
reversible electron transfers is the thiol which contains a sulfhydryl (-SH) group
2
. Redox 
signaling occurs through the interaction of both reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) with thiols. When exposed to these species thiols undergo a variety of 
structural changes that lead to altered states and conformations which can ultimately trigger a 
series of signaling processes within the cell. In addition to reversible forms of oxidation, ROS 
and RNS are also capable of irreversibly oxidizing a thiol in a permanently oxidized state thereby 
eliminating the redox signaling capability of the thiol
2,8
. This typically occurs when higher order 
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oxidation takes place. Figure 1 shows some of the various oxidized products that form when a 
thiol is exposed to ROS and RNS. 
 
SHThiol
Reduced
Oxidized
S-SG
S-SCys
S-SHCy
SNO
SO-
SO2
-
SO3
-
S-Glutathionylation
S-Cysteinylation
S-Homocysteinylation
S-Nitrosylation
Sulfenic Acid
Sulfinic Acid
Sulfonic Acid
 
Figure 1 (Adapted from Go et al. 2013)
8
. Reduced and Oxidized forms of Thiols. 
When a thiol is exposed to reactive oxygen and nitrogen species, a variety of 
products can form as shown. Most of the oxidative modifications shown are 
reversible while sulfinic and sulfonic acids are irreversible forms of oxidation 
produced in highly oxidizing environments. 
 
ROS and RNS come in many forms which can be categorized as either radical or non-radical 
species. Radical species, such as the hydroxyl radical (OH•), superoxide anion (O2
-•), nitric oxide 
(NO•) and nitrogen oxides (NO2•/NO3•), contain an unpaired electron and are highly unstable. As 
such, they are typically more reactive and have shorter life spans since they strip away electrons 
from surrounding sources, such as proteins, lipids and nucleic acids, in order to gain stability
9
. In 
doing so, these components undergo oxidation and are capable of  causing further oxidation until 
two radical species join to terminate the cycle. Non-radical species include hydrogen peroxide 
(H2O2) and peroxynitrite (ONOOH) and do not contain any unpaired electrons yet still show high 
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reactivity towards thiols. While non-radical species are generally less reactive than radical 
species, they have a longer life span and are capable of diffusing membranes which may lead to 
oxidative modifications and signaling processes beyond their initial site of production
9
.  
Of the few chemical compounds that contain thiols, cysteine residues have been the most 
extensively studied in terms of redox biology. This amino acid contains a thiol group that is 
highly susceptible to reactions by ROS/RNS
10,2
. Exposure of thiols to these reactive species can 
alter the thiol to a number of possible oxidized by-products shown above thereby leading to a 
change in protein structure and function. Indeed, many cellular processes are sensitive to redox 
signaling including the regulation of transcription factors, inflammatory responses, metabolism, 
and cell proliferation and differentiation
2,7,11
. Thus, determining the full mechanisms behind 
these and other processes necessitates an understanding of the role played by redox signaling and 
doing so requires sensitive methodologies to measure and detect thiol redox states in both cell 
culture and animal models.  
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Chapter 2: Background 
2.A - Redox signaling as a regulator of cellular function 
2A.1 - Sources of Oxidants  
ROS and RNS are highly reactive radical or non-radical molecules produced within 
organisms as a byproduct of many physiological factors and they serve many essential functions.  
There are a number of in vivo sources of ROS and RNS and the list below highlights some of the 
major contributors to their production.  
The NOX family of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases are 
a group of enzymes capable of transferring electrons from NADPH to oxygen to produce 
superoxide in multiple cellular compartments including plasma membrane, nuclei, cytosol and in 
the mitochondria (Figure 2)
12,13
. While superoxide is the immediate product of NOX enzymes, 
H2O2 can be formed from the spontaneous or enzymatic dismutation of superoxide
14
. The 
balanced production of ROS by the NOX family is important for the regulation of a number of 
cellular signaling processes such as gene expression, cell differentiation, defense and 
posttranslational protein modifications
7,14
. An overproduction of ROS from this source has been 
associated with cardiovascular disease and impairments in gene transcription
12
. 
Xanthine oxidase (XO) is a cytosolic enzyme responsible for the breakdown of purines in 
humans and is a known source of both hydrogen peroxide and superoxide generation within the 
cell with the former being the major product
15
. While low levels of XO-generated ROS play a 
role in antimicrobial defense, increased levels have been associated with tissue damage and 
gout
16,17
. 
Nitric oxide synthase (NOS) plays a regulatory role in vascular homeostasis through the 
coupling of molecular oxygen with L-arginine to produce nitric oxide (NO)
18
. When L-arginine 
levels drop, the enzymatic activity of NOS becomes ‘uncoupled’ such that NOS activity shifts 
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towards superoxide production
18
. There are various NOS isoforms that are located in a number of 
different types of cells and tissues, however they all display similar enzymatic activities with the 
potential to generate ROS and RNS which can lead to cell damage
18
.   
The electron transport chain (ETC) of the mitochondria is another major source of ROS 
within cells. Electron carriers derived from Kreb’s cycle (NADPH, FADH2) that are normally 
transferred down the ETC during oxidative phosphorylation can prematurely ‘slip’ off of the 
ETC and bind to free O2 to produce superoxide which can be converted to H2O2
19,20
. While this 
list of in vivo sources of ROS and RNS is not exhaustive, it highlights the widespread production 
and use of these species within cells (Figure 2) in order to maintain homeostasis through ‘redox 
signaling’ and in conditions of oxidative stress. 
Apart from the physiological sources, ROS and RNS can also be produced by factors 
beyond the organism itself. These external sources include radiation, ozone, environmental 
toxins and behaviours such as smoking
4
. It is thought that these factors can not only be a source 
of ROS but that they can catalyze the formation of ROS and RNS within tissue leading to health 
risks
21
. 
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Figure 2. Common Cellular sources of ROS and RNS. NADPH oxidase (NOX) 
isoforms are located in the nuclei, cytosol and on cell membranes and are capable of 
producing various forms of ROS and RNS. Nitric oxide (NO) can be combined with 
superoxide (O2
-•
) to produce the peroxynitrite anion (ONOO
-
) which can become 
protonated to form the non-radical form. Similarly, xanthine oxidase (XO) is a source 
of both O2
-•
 and hydrogen peroxide. Electrons slipping from ETC complexes in the 
mitochondria produce superoxide radicals which can be converted to hydrogen 
peroxide through the enzyme superoxide dismutase (SOD). Hydrogen peroxide is a 
more stable form of oxidant and is capable of crossing membranes while superoxide 
is relatively unstable and localized. 
 
2A.2 – Redox Signaling 
ROS and RNS play a dual role in physiological processes and the fate of cells. On one 
hand there is evidence to suggest a role in signaling responses to maintain homeostasis and the 
integrity of the cell
10,22,23
. For example, moderate levels of ROS act as secondary messengers for 
cell proliferation, cytosolic calcium concentrations, protein phosphorylation and activation of 
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various transcription factors
24,25
. On the other hand when ROS and RNS levels go beyond 
normal, ‘oxidative stress’ can occur leading to impairments in cellular function and apoptosis2. 
These elevated levels of ROS/RNS could then signal adaptations or, if excessive, lead to cellular 
damage. Thus, alterations in the redox status of cellular components can be thought of as a 
continuum where small changes could be managed and necessary to maintain normal function 
while exceeding the healthy threshold can lead to adaptation or impairments.  
ROS and RNS have been investigated as mediators of many cellular and physiological processes 
through reduction and oxidation of protein residues, specifically cysteines
10
. The thiol groups on 
cysteines have an average pKa value of approximately 8.5 which makes them less likely to react 
with ROS and RNS
26
. However, this value drops substantially in the presence of other protein 
domains and in the conditions of the surrounding microenvironment. In this case, cysteine thiols 
typically have a pKa value of 4 or less depending on the environment and they exist in the 
thiolate anion form (S
-
) at plasma pH (7.1)
11
. This renders the cysteine more reactive with ROS 
and RNS compared to the thiol (SH) form
27
. The resulting perturbations in the redox state of 
cysteine thiols can alter the shape, structure and, ultimately, the function of proteins, lipids and 
nucleic acids
20
 and can lead to a sequence of physiological events through redox signaling 
pathways. Table 1 shows some of the redox sensitive proteins that have been investigated. 
 
Table 1. List of Redox-sensitive Proteins Identified in Various Studies
28–33
.  
Function Protein 
DNA repair Ku80 
 MCM6 
 80kDa MCM3-associated protein 
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Metabolism Acyl-CoA dehydrogenase 
 Alcohol dehydrogenase 1 and 2B4 
 Aldose 1-epimerase 
 Amino acid transporter E16 
 C1-tetrahydrofolate synthase 
 Carnitine acetyltransferase 
 Catechol-O-methyltransferase 
 Complex III of mitochondrial electron 
transport chain 
 Enolase 1 and 2 
 GAPDH 
 Glucosidase alpha 
 Iron-sulfur protein assembly 1 homologue 
 Malate dehydrogenase 
 Mitochondrial creatine kinase 
 Neutral amino acid transporter B 
 Phosphoglycerate kinase 
 PTP1B 
 Pyruvate dehydrogenase, E3 binding protein 
 Pyruvate dehydrogenase kinase, isoenzyme 
2 
 Voltage dependent anion channel 1 
Antioxidant System 2-Cys peroxiredoxin 
9 
 
 Ascorbate peroxidase 
 manganese superoxide dismutase 
 thioredoxin-dependent preoxidase 1 
Nuclear Transport Importin 9 
 Karyopherin Beta 1 
 Ran 
 20S proteasome alpha subunits A1, B1, G1 
and E 
Protein Homeostasis Calnexin 
 Calreticulin 
 ER-Golgi intermidiate compartment protein1 
 Hs7p75 (TRAP1) 
 Hsp90-alpha 
 Tripeptidyl Peptidase II 
 Ubiquitin-activating enzyme E1 
Protein Synthesis Gln-tRNA synthetase 
 hnRNP U protein 
 Met-tRNA synthetase 
 Ribosomal protein S3 and S6 
 Thr-tRNA synthetase 
 U2 small nuclear RNA auxiliary factor 1 
Transcription and Translation Elongation factor 1-alpha 
 Elongation factor 1B alpha-subunit 2 
10 
 
 Translation elongation factor Ts 
 Nrf2 
 Yap1p 
Post-translational Control/Modification Calretriculin 1 
 Chaperonin-60 alpha 
 Cytosolic Cyclophilin 
 Phosphoprotein phosphatase 
 Protein disulfide isomerase-like protein 
Cytoskeleton Actin 7 
 Tubulin alpha-6 chain 
 Tubulin beta-2 
Redox Homeostasis Glutathione transferase Mu 3 
 Peroxiredoxin I 
Signaling Aspartyl β-hydroxylase 
 Cardiotrophin-like cytokine factor 1 
 IQGAP1 
 G protein, β polypeptide 2 
 Pl-3-kinase, catalytic subunit 
 Protein phosphatase PP1, catalytic subunit 
 SH2 domain-containing adapter protein F 
Vesicle transport Rab1a 
 Rab10 
 Rab33b 
11 
 
 
As previously stated, an important requirement for redox signaling is the ability of a thiol 
to alternate between reduced and oxidized states. The reversibility of redox status provides a 
mechanism by which proteins and enzymes can activate or deactivate their activity. For instance, 
it has been established that protein-tyrosine phosphatases contain active site cysteines that can 
become oxidized thereby inactivating the enzyme and preventing dephosphorylation of targets
34
. 
Similarly, certain metabolic enzymes, including GAPDH, have been shown to be regulated by 
changes in redox status of their active site cysteines
35
. In considering that many caspases, 
kinases, phosphatases and proteases contain active site cysteines
2
, redox signaling may play a 
potential role in being a significant regulator of many cellular processes via reversible oxidation 
through changes shown in Figure 1.  
Disulfide bonds are known to cause signaling by changing protein structure and protein 
folding. Cysteines are a critical part of secondary, tertiary and quaternary protein structure due to 
their ability to form disulfide bonds between other cysteines
2
. Changing the protein or enzyme 
structure through changes in cysteine thiol redox state can ultimately lead to altered function and 
provide yet another means for redox signaling to occur.  
When considering the large number of redox sensitive proteins and the various signaling 
cascades that may occur in response to varying levels of oxidation, researchers who are interested 
in determining the effects of ROS and RNS on cellular function may benefit from methods that 
allow accurate determination of whole cell redox states which can then be used in concert with 
protein-specific measures of redox status. Section B will cover some of the common methods 
used to detect changes in redox state. 
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2A.3 - Major Redox Buffering Mechanisms 
Under normal healthy conditions the rate of ROS/RNS production is balanced by their 
removal with the help of a number of enzymatic and non-enzymatic antioxidant systems. 
Examples of enzymatic antioxidants include superoxide dismutase (SOD) which catalyzes the 
breakdown of the superoxide radical into hydrogen peroxide and catalase which converts 
hydrogen peroxide into water. While there are a number of non-enzymatic redox buffering 
mechanisms, such as vitamins C and E, the major one is reduced glutathione (GSH). GSH is the 
most abundant redox buffer in cells and is present in millimolar concentrations
25
. If a protein 
thiol undergoes reversible oxidation, GSH is able to donate its electrons via glutaredoxin (Grx) to 
oxidized proteins in order to return them to the reduced state
36
. In doing so, GSH itself becomes 
oxidized to form a thyl radical (GS•) which can react with other GS• molecules to form oxidized 
glutathione (GSSG)
25
. GSSG can then be reduced back to GSH by the glutathione reductase 
(GR) enzyme which depends on NADPH as the source of electrons
25
.  
Thioredoxin (Trx) also acts as a redox buffering mechanism in both a direct and indirect fashion. 
Trx can directly reduce oxidized proteins by transferring its electrons and also acts to indirectly 
convert H2O2 to water through peroxiredoxin (Prx)
36
. For both redox buffering pathways (Grx 
and Trx), NADPH is the master reducing system derived from the pentose phosphate pathway of 
glucose metabolism. This reducing agent provides the electrons necessary for the majority of 
antioxidant defenses within cells
36
. Figure 3 represents this defense system. When the production 
of ROS/RNS exceeds the antioxidant capacity of the cell, oxidative/nitrosative stress can occur 
leading to cell death and disease. 
13 
 
ROS/
RNS
 
Figure 3. Major Enzymatic Antioxidant System within Cells. NADPH provides 
the reducing power to most of the antioxidant pathways in cells. Oxidized glutathione 
(GSSG) accepts an electron from NADPH to become reduced (GSH) with the help of 
glutathione reductase (GR). GSH can either donate its electron to glutathione 
peroxidase (Gpx) which converts H2O2 to water or it can donate the electron to 
glutaredoxin (Grx) which then donates the electron to an oxidized protein, thereby 
reducing it. Thioredoxin (Trx) can also accept electrons from NADPH to directly 
reduce proteins or by indirectly converting H2O2 to water through peroxiredoxin 
(Prx) (adapted from Ng et al)
37
. 
 
It is through this antioxidant system that cysteines are regulated as part of redox signaling. 
Ultimately, these redox recycling mechanisms dictate the redox state of a given protein and 
indeed the entire redox proteome which is often referred to as ‘cellular redox state’.  
 
2A.4 - Cellular Redox State: Relationship to Cellular Functions 
Physiological signaling processes often involve more than a single regulatory site. 
Therefore, when attempting to understand these processes, it becomes useful to consider overall 
14 
 
changes as well. Similarly when considering redox signaling pathways, it is important to 
investigate global changes in redox states in response to stressors since 1) it may be useful to 
determine large-scale changes in redox states after a stress has been introduced to a particular site 
and 2) small changes in redox states can trigger a cascade of signaling events that alter the redox 
states of multiple sites within the cell. 
Instances where a researcher may find it helpful to measure cellular redox states may 
include normal daily fluxes in redox states in response to mild stressors. For example, in a study 
by Anderson et al. it was found that rodents on a 3-day high-fat diet had significantly elevated 
levels of mitochondrial H2O2 emission. In addition, they found that the GSH/GSSG ratio, an 
indirect measure of whole cell oxidation, was significantly lower in high-fat fed mice indicating a 
more oxidized state
38
. Therefore, acute challenges can alter whole-cell redox states and 
measuring this parameter would provide insight to these changes. 
Research benefiting from the determination of whole cell redox states can also be 
extended to pathophysiological conditions. Changes in global redox status of cells have been 
implicated in a variety of chronic diseases. Oxidative and nitrosative stress caused by 
overproduction of ROS and RNS has been studied due to their role in aging
39,40
, muscular 
dystrophies
41–44
, metabolic disorders
45–48
, neurodegenerative disorders
3,49
 and cancer
20,50–52
. A 
common characteristic shared by these diseases is an increased rate of overall ROS/RNS 
production with a concomitant decrease in antioxidant defense systems resulting in a cycle of 
increasing oxidative damage and decreased cell function which  ultimately leads to DNA and 
protein damage on a whole-cell level. For example, several studies have found associations with 
oxidative stress and neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease, in 
which oxidative damage to proteins, lipids and DNA was significantly higher in neuronal cells 
compared to controls
3,53–64
. When considering the high reactivity of ROS/RNS with lipids, 
15 
 
proteins and nucleic acids, it should come as no surprise that the accumulation of these factors 
can cause damage that may lead to altered cell-signaling and impaired function which could 
ultimately lead to illness. Assessment of oxidative damage in diseases like those mentioned 
above was based on methods targeting specific markers of oxidative stress (carbonylation for 
protein oxidation, 4-Hydroxynonenal for lipid oxidation and 8-hydroxy-2’deoxyguanosine for 
DNA oxidation) rather than a whole-cell approach to determine overall cellular redox state. To 
gain a better understanding on the relationship between oxidative states and disease, it may be 
necessary to consider methods that measure total changes in cellular redox state as opposed to a 
single marker of oxidation. 
 
2B - Current Methods for Determining Protein Redox State 
2B.1 - Mass Spectrometry 
Given the critical importance of ROS/RNS in cell signaling and health, several methods 
have been developed to accurately detect the type and extent of redox modifications on 
biological samples. Mass spectrometry (MS) is one of the most commonly used techniques in 
metabolic research and has been growing in popularity over the years
65,66
. As such, it has been 
used in a variety of studies as a method to determine redox modifications with high specificity
67–
69
. A typical MS procedure works by first ionizing a sample, forming fragments of charged 
particles. These particles are then detected based on their mass-to-charge ratio which is then 
correlated to known masses to determine the chemical composition in the original sample. As an 
analytical tool, MS offers a number of distinct advantages including high specificity, providing 
information on molecular weight and isotopic abundance of chemical species, and the ability to 
be combined with a number of other separation techniques (i.e. chromatography). While this 
16 
 
method is appealing due to its sensitivity and accuracy, typical mass spectrometers can cost 
upwards of hundreds of thousands of dollars and require a high degree of technical training for 
its implementations. Hence its use is not accessible for many laboratories and is limited to many 
researchers due to the high levels of training requirements. 
2B.2 - GSH:GSSG Ratio 
The ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG) is often used as a 
marker of total protein oxidation within a sample. When proteins are reversibly oxidized (e.g. 
disulfide bond formation, other), they can be returned back to the reduced state by GSH, which 
donates an electron to the oxidized protein to cause reduction
36
. As mentioned above, GSH 
transfers its electron to reduce an oxidized protein thiol and becomes converted to GS• which is 
capable of forming a disulfide bond with a second GS•.  This oxidized complex, referred to as 
GSSG, is incapable of further protein reduction.  A low GSH:GSSG is therefore used as a marker 
for global cellular protein oxidation
70
 and can be determined both colorimetrically, as described 
below, or by high performance liquid chromatography (HPLC)
71
. While a common assumption 
with this method is that a change in GSH:GSSG ratio will reflect a change in whole-cell redox 
state,  it may be that the assumption does not apply to the entire redox proteome. Direct measures 
of cellular and protein redox states could reveal surprising heterogeneity across the proteome. 
Furthermore, the sensitivity of the of 5,5’-dithio-bis-(2-nitrobenzoic acid (DTNB)-linked 
colorimetric kit for detecting GSSG has been questioned in our own lab and others (data not 
shown) whilst the more sensitive HPLC is often not accessible to many laboratories.  
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2B.3 - Thiol Assay Kits  
Along with the thiol and oxidation-specific probes mentioned above, various colorimetric 
and absorbance-based kits are commercially available for researchers interested in measuring 
thiol content in a sample. These assays typically incorporate a compound that leads to a colour 
change when reacted with thiols and allows the investigator to determine the thiol concentration 
through a standard curve. A commonly used assay involves the use DTNB which produces a 
yellow solution in the presence of thiols thereby allowing researchers to quantify total thiol 
content in a sample. While simple to use, this method lacks specificity between free thiols and 
thiol groups on cysteines and would have limited use to investigations that need to discriminate 
between the two. Many similar colorimetric kits are available that work under the same principle 
however this method is limited by its sensitivity and specificity when compared to the 
fluorometric approaches mentioned above. As such, a method that addresses these issues while 
offering simple, reliable and easy to use protocols would be of benefit to many investigators. 
2B.4 - Oxidation-Specific Probes 
When proteins become oxidized they can undergo a variety of modifications resulting in a 
number of different oxidized compounds, such as glutathionylation, carbonylation, nitrosylation 
or sulfur-based acids, to name a few
72
. Specific probes for each modification are becoming 
available
73,74
 and are useful for determining the role of a particular modification in redox 
signaling. For example, Oxyblot kits are commonly used to measure protein carbonylation using 
western blotting approaches. This assay is based on the reaction of carbonylated proteins with 
2,4-dinitrophenylhydrazine (DNPH). While relatively easy to use, these assays have a number of 
disadvantages. Mainly, they have been criticized for their inability to yield reproducible results 
which may stem from the degradation of their proprietary components
75
. Furthermore, these 
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methods do not confirm whole-cell redox state in terms of total thiol oxidation of all forms and 
limit the researcher by measuring only one form of oxidation.  
As an alternative to oxidation product-specific probes, a number of probes specific for 
reduced thiols with wide spectral ranges and sensitivities have been developed to measure protein 
redox states. Iodoacetamide and maleimide based probes are commonly used in redox studies as 
they irreversibly react with reduced thiols at their specified pH ranges. Iodoacetamide dyes, such 
as boron-dipyrromethene (BODIPY) fluorophores and eosin-5-iodoacetamide, and maleimide 
dyes such as Cyanine5 (Cy5) and Alexa Fluor 647 C2 maleimide, have been used for their 
specificity towards thiol groups and their ability to be incorporated with gel electrophoresis. 
However, specificity of these dyes towards thiols tends to decline when they are used above a 
certain concentration
76
 and it has even been reported that iodoacetemide-based dyes react with 
methionine, tyrosine and histidine which can confound results aimed at measuring reduced 
thiols
77
. Another disadvantage of these probes is that their emission spectra tend to lie in the 
visible range. It has been argued that detection in this region, especially near lower wavelengths, 
leads to low signal-to-noise ratio when compared to images obtained in the near-infrared (NIRF) 
range
78
. Therefore, while these probes are commonly used, many precautionary steps must be 
taken to ensure proper detection of thiols with minimal noise. In many cases, these probes should 
also be validated against proven methods (HPLC, MS) for thiol detection since there is currently 
very little data available on these newly available dyes. 
 
2B.5 - Thiol Redox State Detection with DIGE 
We have mentioned a number of tools that are currently available to researchers who are 
interested in measuring the redox state of cells and proteins. An important consideration to make 
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when discussing measurement of thiol redox states is whether we want to measure the reduced 
state or the oxidized state of proteins or cells. While probes are available for the detection of 
either form of modification, it may be more efficient for a researcher to choose one. In their study 
of measuring vicinal dithiols within mitochondria, Murphy et al. have proposed that measuring 
oxidation is more sensitive using the Redox difference in gel electrophoresis (DIGE) method
79
. 
In brief, this procedure incubates samples with N-ethymaleimide (NEM) to irreversibly block 
reduced thiols in their reduced state. The entire sample is then incubated with the reducing agent 
dithiothreitol (DTT) to reversibly reduce any remaining oxidized thiols and the sample is then 
incubated with a fluorescent maleimide-based dye specific to reduced thiols (Cy5)
79
 prior to 
detection. This method essentially measures samples that were originally in the oxidized state. 
The major limitation to this DIGE method is that it relies on reversible oxidation of thiols and 
does not account for many irreversible forms of oxidation that may occur. Furthermore, while it 
is claimed that this method is more sensitive than measuring reduced states of thiols, the report 
fails to make a comparison to the latter in order to validate this. Currently, it is still unclear 
whether measurement of reduction or oxidation will yield more sensitive results. While oxidation 
can lead to many products, reduction of thiols has the potential of being more simple and 
sensitive for determining shifts in protein redox state.  
 
2C - Barriers to simplified detection of cellular redox state in tissue lysate 
As noted above, while a variety of approaches are being developed or are in use to detect 
oxidation-specific products on protein thiols, there are many cases where thiol redox state is 
required regardless of the oxidation product.  Thus, in order to determine whether a protein is 
oxidized in any form, or reduced, it is clear that direct detection of thiol redox state would be 
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superior to indirect methods (e.g. GSH/GSSG).  The availability of several maleimide-based 
fluorophores for labeling reduced cysteines has made it possible to detect protein redox state with 
gel electrophoresis.  As discussed above, in-gel detection offers a considerable advantage over 
mass spectrometry given the widespread availability and low cost of electrophoresis 
infrastructure and expertise. However, the sensitivities of the fluorophores themselves have not 
consistently been reported
79
 which makes it challenging to select an ideal probe for protein 
labeling based on the available literature, and not all validations have comprehensively validated 
the dyes with both oxidation and reduction challenges in vitro and in vivo
26,79–81
.  Furthermore, 
anecdotal feedback from many investigators (unpublished) indicates that the assays are difficult 
to establish or signals are too weak to detect in mixed protein lysates.  This may be related to the 
use of poorly binding or insensitive probes.  For example, many of these probes often require 
saturating concentrations of probe that may result in poor protein yields given labeled proteins 
tend to precipitate
80
.  Furthermore, unpublished findings from our lab has noted the considerable 
variability of results that can be attributed to various experimental assay parameters such as 
diverse effects of detergents, which has also been reported by one group with certain 
fluorophores
80
, poor fluorescent signals in protein-rich lysates and generally weak signals in dyes 
fluorescing in the visual wavelength.  There is a clear need to resolving multiple experimental 
parameters in order to provide a simplified and sensitive method for direct-detection of protein 
redox state that can be easily and affordably adopted by laboratories with common gel 
electrophoreses infrastructure.  
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Chapter 3: Purpose 
The purpose of this thesis was to resolve a series of technical limitations to direct 
detection of cysteine redox state of proteins from muscle tissue lysates using common mini-gel 
electrophoresis infrastructure. We employed a recently developed infrared fluorescent-tagged 
maleimide (IRDye 800CW Maleimide, Licor) given infrared fluorescence is known to provide 
less background and greater sensitivity than visual wavelength fluorescence.  This thesis also 
aimed to resolve a number of experimental barriers that our lab has identified (unpublished) to 
prohibit detection of thiol redox state using gel electrophoresis.  A simplified protocol is then 
provided which addresses how thiol labeling with IRDye 800CW Maleimide is affected by a 
common cell lysate detergent, the presence of endogenous low molecular weight compounds and 
the effect of pH on common reducing controls.  We also determined whether oxidation/reduction 
challenges create homogeneous or heterogeneous responses throughout the redox proteome 
between 25-100kDa in comparison to a single ‘whole-cell’ assessment using in-well detection.  
Finally, the in-gel approach of detecting thiol reduction was compared to the reverse DIGE 
method of quantifying thiol oxidation in order to determine which method is more sensitive at 
capturing changes in redox state in response to oxidation/reduction challenges.  These results 
were also compared to the more common but indirect assessments of protein oxidation 
(GSH/GSSG and carbonylation). 
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Chapter 4: Methods 
Sample preparation and treatment 
Sprague Dawley heart was harvested, rinsed with 0.9% saline and immediately frozen in 
liquid nitrogen. Frozen tissue was chipped in liquid nitrogen and homogenized in a plastic 
microcentrifuge tube with a tapered Teflon pestle in ice cold Tris Buffer (144.5mM Tris, 
1.44mM MgCl2, pH 7.1) containing protease inhibitor cocktails and phosphatase inhibitors 
(Sigma, St. Louis, MO, cat #: P0044, P5726). Supernatants were obtained by centrifugation at 
13,500 rpm for 10 minutes at 4⁰C and separated into 130µl aliquots. Each aliquot was spun twice 
consecutively through a Zeba desalting column (Pierce, Rockford, IL, cat # 89882) with a 
filtration size of 7kDa. Protein concentration was determined using the bicinchoninic acid (BCA) 
assay kit (Pierce, Rockford, IL, cat # 23227) and each sample was diluted to equal protein 
concentration and volume. This was followed by incubation with either 5mM dithiothreitol 
(DTT) (Bioshop, Burlington, ON, DTT002.5) 1mM tris (2-caroxyethyl) phosphine) (TCEP; 
Pierce, Rockford, IL, 20490) as thiol reduction controls or 5mM H2O2 (Sigma, St. Louis, MO, 
323381) containing 0.5% sodium iodide (NaI) (Sigma, St. Louis, MO, 217307) as oxidation 
controls for 5 minutes at room temperature on a rotating nutator. From this point on, all samples 
were protected from light as much as possible to prevent the breakdown of any light-sensitive 
reagents such as IRDye800CW-Maleimide, TCEP, DTT, H2O2 and NaI. Some samples that were 
treated with 5mM H2O2 + NaI were subsequently treated with TCEP to see reversible effects of 
reduction on pre-oxidized samples. These ‘rescue’ conditions were treated with the same 5mM of 
H2O2+NaI, desalted through Zeba columns to filter small molecules below 7kDa to remove 
excess reagents and then treated with 1mM TCEP before continuing with the next steps. 
23 
 
After incubation, all samples were desalted twice using Zeba columns which retain anything at or 
below 7kDa to remove excess reagents. The protein concentration of each sample was then 
determined using another BCA protein assay. For experiments using reducing agents such as 
DTT and TCEP, a reducing agent-compatible BCA kit was used (Pierce, Rockford, IL, 
cat#23252). Once protein content was determined, samples were diluted to equal volumes and 
protein concentrations. IRDye800CW-Maleimide was then added at a ratio of 400µM for every 
200µg of protein. Samples were incubated with dye overnight at 4°C on a rotating nutator. The 
following day samples were desalted a final time to remove excess dye prior to preparation for 
western blotting. 
 
Western Blotting and in-well assays 
Another BCA protein assay was conducted to prepare equal proteins for western blotting 
samples. For all western blots, 2µg of protein was loaded per lane on polyacrylamide running 
gels of 10% and subjected to SDS-PAGE at 160 volts for 75 minutes until the blue front from the 
laemelli’s reagent ran off the bottom of the gel. Gels were detected at emission wavelengths of at 
800nm and 700nm fluorescent wavelengths for the dye and protein standard (Bio-Rad, 
Mississauga, ON, 161-10374) respectively using the Odyssey infrared imaging system (Licor 
Biosciences, Lincoln, NE, Model # 9120). All gels were scanned at an intensity unit of 5 for both 
800 and 700nm channels 
Similarly for the in-well assays using 96-well plates, 2µg of each sample was loaded into 
a well and topped up to a final volume of 200µl per well with double distilled water (ddH2O). 
The well was then scanned on the Odyssey imaging system using a lower intensity unit of 2 to 
eliminate background and plate reflection. In order to determine any background interactions 
between IRDye800CW-Maleimide and other reagents (TCEP, H2O2+NaI), separate wells were 
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loaded with either ddH2O, 1mM TCEP or 5mM H2O2+NaI with100nM IRDye800CW-
Maleimide and brought to a final volume of 200µl. 
 
Heat treatment 
Given that heat is a known to alter the redox state of cellular proteins
25,82–84
, we used this 
model to trigger altered redox states in our samples. Frozen cardiac muscle was placed in 
solution containing (mM): NaCl, 145; KCl, 3; CaCl2, 2.5; MgCl2, 1 and Hepes, 10 with a final 
pH of 7.4. This buffer was pre-heated to either 40⁰C or 49⁰C in a dry bath incubator prior to 
addition of frozen tissue while controls remained at room temperature. Following 45 minutes 
incubation at their respective temperatures, control and heated samples were removed, quickly 
blotted dry and placed in Tris buffer containing protease and phosphatase inhibitors for 
homogenizing following the steps outlined previously.  
 
Redox-DIGE 
Heated samples subjected to our optimized and direct redox protocol were compared to a 
modified redox method by Murphy et al.
79
. In this difference in gel electrophoresis (DIGE) 
method, heated samples were incubated with 50mM N-ethylmaleimide (NEM) (Sigma, St. Louis, 
MO, E3876) followed by two consecutive washes through Zeba columns to remove excess NEM. 
Samples were then reduced with 2mM TCEP and desalted again to remove excess TCEP. Protein 
concentration was then determined and samples were diluted to equal volumes and protein 
concentrations followed by an overnight incubation with IRDye800CW-Maleimide at 4°C. 
Western blotting procedures outlined above were then conducted the next day. 
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GSH and GSSG measurements using HPLC 
Tissue was homogenized in Tris buffer containing (mM): 50Tris, 20 boric acid, 2 L-
serine, 20 acivicin and 5 NEM at a pH of 8. To deproteinate our samples, trichloroacetic acid was 
added to homogenate for GSH, and perchloric acid was used for GSSG. Deproteinated samples 
were vortexed vigorously and centrifuged at 14,000RPMfor 5 minutes at 4°C. Supernatants was 
collected and sampled through a High-Pressure Liquid Chromatography (HPLC) system 
(Agilent, Santa Clara, CA, 1100 Series)equipped with a 4.6 x 150mm, 5-micron column 
(ZORBAX Eclipse XDB-C18, Agilent, Santa Clara, CA). GSH measurements were taken using 
ultraviolet emissions picked up by the variable wavelength detector. The mobile phase for GSH 
was 0.25% glacial acetic acid in HPLC-grade water, flow rate of 1.25ml/min (pH 3.1). For GSSG 
analysis, 200µl of supernatant was added to 1ml of 0.5M NaOH followed by a15 minute light-
protected incubation with75µl 0.1% o-Pthaldialdehyde (OPA), a fluorescent probe. Mobile phase 
for GSSG separation was sodium phosphate dibasic. Eluted GSSG was directed to a high 
resolution fluorometer (QuantaMaster 40, HORIBA Scientific, Edison, New Jersey) in a high 
pressure flow-through cuvette (Firefly Sci, Brooklyn, NY, 8830). GSSG mobile phase consisted 
of sodium phosphate dibasic, flow rate of 0.5ml/min. Using GSH and GSSG standard curves, 
both GSH and GSSG were expressed as µmol/g protein.  
 
Carbonylation 
All procedures for derivitization of protein carbonyls with 2,4-dinitrophenylhydrazine 
(DNPH) were conducted using the Oxy blot kit (S7150, Millipore, Etobicoke, ON). Briefly, 
carbonyl products  react with DNPH to form 2,-4-dinitrophenylhydrazone (DNP-hydrazone) 
which is subsequently measured using chemiluminescence. 15μg of protein was loaded from 
heated (40°C or 49°C) and control heart muscles from Sprague Dawley rats. Proteins were 
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denatured with 12% SDS followed by derivatization (DNPH solution or control) for 20min with 
gentle agitation at room temperature. The derivatization reaction was stopped with the addition 
of neutralization solution and samples were reduced with 2-mercaptoethanol (5%v/v). Proteins 
were separated on a 12% polyacrylamide gel and transferred onto a polyvinylidene fluoride 
(PVDF) membrane. Membranes were blocked in odyssey blocking buffer for 1 hour prior to 
overnight incubation with primary antibody (1:150, Rabbit Anti-DNP). On the following day 
membranes were washed with TBST and incubated with goat anti-rabbit IgG 680 (Licor, 926-
68071) for 1 hour and imaged (Odyssey, Licor Bioscience). 
 
Data Analysis and statistics 
Densitometry of fluorescence was quantified for all western blots and microwell plate 
analyses using the Licor Odyssey software version 2.0.13. Lanes were selected between 25-
100kDa while specific bands at 60kDa, 44kDa and 25kDa were individually assessed to 
determine their influence on whole-lane fluorescence. For in-well images, the entire well was 
selected for quantification of fluorescence densitometry values. Gel data comparing control, 
oxidized (5mM H2O2+NaI) and rescued (sequential 5mM H2O2+NaI oxidation with 1mM TCEP 
reduction) conditions was analyzed using a Friedman’s non-parametric test. Plate data comparing 
the same conditions passed the Kolmogorov-Smirnov test for normality and was analyzed using a 
one-way ANOVA with repeated measures. The Student Newman-Keuls post hoc test was used to 
identify which means were significantly different from each other. Results are expressed as mean 
±SEM. Significance for all stats was established at P<0.05. All data comparing only 2 groups 
were analyzed using a paired two-tailed t-test. 
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Chapter 5: Results 
 Prior to obtaining the results outlined in this section, a number of important optimization 
steps had to be performed in order to determine the appropriate conditions for the IRDye800CW 
Maleimide to accurately detect reduced thiols. Most of these steps are outlined in the appendix 
while some are shown in this section.  
 
Effects of Desalting Samples Prior to Dye Treatment 
Filtering homogenates through a desalting column prior to incubating with IRDye800CW 
Maleimide resulted in an increased signal in these desalted (D) conditions compared to no 
desalting (ND). This observation was found to occur in gel for both CHAPS buffer (ND: 1.93 ± 
0.21 a.u, D: 35.63 ± 2.44 a.u, p<0.05) and Tris buffer (ND: 1.28 ± 0.39 a.u, D: 33.34 ± 4.39 a.u, 
p<0.05, Figure 4a). Similar results were observed using an in-well approach in CHAPS (ND: 
1.43 ± 0.18 a.u, D: 12.66 ± 0.51 a.u, p<0.05) and Tris (ND: 2.56 ± 0.39 a.u, D: 11.89 ± 1.79 a.u, 
p<0.05, Figure 4c). Desalting also led to a decrease in GSH content (2.92 ± 0.07 µmol/g, p<0.05) 
compared to non-desalted controls (3.35 ± 0.09 µmol/g, p<0.05, Figure 5). After determining that 
desalting prior to dye incubations greatly enhances our fluorescent signal, we proceeded to 
incorporate this important step in our remaining experiments for all treatment conditions that 
would be subjected to IRDye800CW Maleimide incubations. 
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Figure 4. Effects of desalting homogenates prior to dye treatment in gel (a and 
b) and in plate (c and d). Desalted samples (D) showed much greater fluorescence 
compared to non-desalted (ND) samples in both CHAPS (pH 7.5) and Tris (pH 7.1). 
Results represented as mean ± SEM. N=4-6. * indicates significant difference from 
ND, p<0.05. 
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Figure 5. Effects of desalting on GSH content. The desalted condition (D) led to a 
significant decrease in GSH content of homogenates when compared to the non-
desalted (ND) condition. Results represent mean ± SEM. N=6. * indicates 
significantly different from ND, p<0.05. 
 
Quenching Effects of Reagents on IRDye800CW Maleimide 
 In order to determine the interactions between oxidizing (H2O2+NaI) and reducing 
(TCEP) agents with IRDye800CW Maleimide, we performed a test to determine whether 
quenching of fluorescence occurred in the presence of these reagents. There was a significant 
decrease in fluorescence between H2O2+NaI and TCEP in dye compared to the dye alone 
(IRDye: 282.4 ± 40.54 a.u, IRDye +OX: 228.06 ± 38.76 a.u, p<0.05, IRDye + RED: 224.18 ± 
40.8 a.u, p<0.05, Figure 6) 
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Figure 6. Quenching effects of reagents on IRDye800CW Maleimide.  The use of 
5mM H2O2+NaI (OX) or 1mM TCEP (RED) in conjunction with IRDye had a small 
but significant effect on fluorescence compared to IRDye alone. Results represent 
mean ± SEM. N=7. * indicates significantly difference from IRDye 
 
Effects of Oxidizing and Reducing Agents on IRDye800CW Maleimide Fluorescence 
 After treating separate homogenates with oxidizing (H2O2+NaI) and reducing (TCEP) 
agents, in-gel fluorescence was measured to determine if the dye accurately detects the respective 
changes in redox states brought about by these reagents. When considering absolute fluorescence 
values, oxidized samples were significantly lower than controls while reduced samples were not 
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significantly different from controls (Control: 1.64x10
6
 ± 0.67x10
6
 a.u, Oxidized: 0.027x10
6
 ± 
0.01x10
6
 a.u, p<0.05, Reduced: 1.11x10
6
 ± 0.49x10
6
 a.u, Figure 7). 
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Figure 7. Effects of reducing and oxidizing samples on IRDye800CW Maleimide 
in-gel. Only oxidized samples were significantly different than controls while 
reduced samples showed a trending yet insignificant decrease. Results represented as 
mean ± SEM. * indicates significant difference from control, p<0.05.  N=6. 
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Rescuing Effects of oxidized samples with TCEP 
 We proceeded to test the ‘rescuing’ effects TCEP would have on samples that had been 
pre-treated with H2O2+NaI in order to determine its efficacy as a reducing agent. Using 
IRDye800CW Maleimide in an in-gel approach showed that the oxidized group was significantly 
lower than control fluorescence while the rescue condition showed no difference (Control: 
107.48 ± 4.71 a.u, Oxidized: 3.29 ± 1.21 a.u, p<0.05, Rescued: 100.82 ± 20.77 a.u, Figure 8a). 
With the in-gel approach, a significant decrease in fluorescence was observed in the reduced 
conditions when normalized to control (Reduced: 0.77 ± 0.03 a.u, p<0.05, Figure 8b inset) 
however this difference was abolished when comparing absolute fluorescent values (Reduced: 
70.18 ± 11.51 a.u, Figure 8b). Using the plate approach, oxidized samples were significantly 
lower than control and rescued conditions (Control: 6.27 ± 1.14 a.u, Oxidized: 0.098 ± 0.024 a.u, 
Rescued: 6.68 ± 1.02 a.u, Figure 9a). When compared to control, reduced samples showed 
significantly greater fluorescence when (Reduced: 7.54 ± 1.28 a.u, P<0.05, Figure 9b).  
We also determined the GSH and GSSG content as well as the ratio of GSH/GSSG to 
determine the repeatability of results obtained through in-gel and plate approaches. We found no 
significant difference in GSH content between control, oxidized and rescued conditions (Control: 
30.55 ± 2.33 µmol/g, Oxidized: 31.39 ± 2.91 µmol/g, Rescued: 31.61 ± 1.71 µmol/g, Figure 10-
a1). Similarly, no differences were found between control and reduced conditions in GSH 
content (Reduced: 30.71 ± 1.67 µmol/g, Figure 10-a2). GSSG content showed no difference 
between control, rescued and reduced conditions, however the GSSG content of oxidized 
samples was elevated (Control: 1.1 ± 0.095 µmol/g, Oxidized: 1.55 ± 0.18 µmol/g, Rescued: 1.22 
± 0.11 µmol/g, Reduced: 1.07 ± 0.09 µmol/g, Figure 10-b1 and b2). The ratio of GSH/GSSG 
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showed no differences between groups (Control: 27.48 ± 3.4 µmol/g, Oxidized: 21.36 ± 2.69, 
Rescued: 26.64 ± 1.73, Reduced: 28.1 ± 2.11, Figure 10-c1 and c2). 
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Figure 8. Rescue effects of TCEP on pre-oxidized samples using in-gel approach.  
In the rescue condition, samples were first oxidized with H2O2+NaI and then treated 
with TCEP. This returned fluorescence of oxidized samples back to control and 
reduced levels (a) with the same statistical findings relative to control (graph not 
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shown). No significance was found between control and reduced samples (b) 
however when considering fluorescence relative to control, reduced samples showed 
a significant decrease (b. inset) Results represented as mean ± SEM. N=4-6. * 
indicates significantly different from Control, p<0.05. 
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Figure 9. Rescue effects of TCEP on pre-oxidized samples using in-well 
approach.  In the rescue condition, samples were first oxidized with H2O2+NaI and 
then treated with TCEP. This returned fluorescence of oxidized samples back to 
control (a) The reduced condition showed greater fluorescence compared to (b). 
Results represented as mean ± SEM. N=6. * indicates significantly different from 
Control, p<0.05. 
 
35 
 
0
10
20
30
40
G
S
H
 (
µ
m
o
l/
g
 p
ro
te
in
)
0
10
20
30
40
G
S
H
 (
µ
m
o
l/
g
 p
ro
te
in
)
0.0
0.5
1.0
1.5
2.0
G
S
S
G
 (
µ
m
o
l/
g
 p
ro
te
in
) *
0.0
0.5
1.0
1.5
G
S
S
G
 (
µ
m
o
l/
g
 p
ro
te
in
)
Control Oxidized Rescued
0
10
20
30
40
50
G
S
H
/G
S
S
G
Control Reduced
0
10
20
30
40
G
S
H
/G
S
S
G
Rescue Effects of  TCEP on GSH and
GSSG Content
a1
b1
c1 c2
b2
a2
 
Figure 10. Effects of reducing and oxidizing agents on GSH, GSSG and 
GSH/GSSG. No difference was observed in GSH content (a), GSSG (b) or 
GSH/GSSG (c) however there is a trending increase in GSSG for oxidized samples 
(b1) and a trending decrease in their GSH/GSSG ratio (c1). Results represented as 
mean ± SEM. N=5-6. 
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Heat-induced changes in redox states 
49⁰C Treatment 
 With respect to the direct detection of reduced thiols using our optimized protocol with 
IRDye800CW Maleimide, exposure of tissue samples to 49°C temperatures led to a significant 
decrease in fluorescence in the 25-100kDa range using the in-gel approach relative to control 
(49⁰C: 0.315 ± 0.07 a.u, p<0.05, Figure 11e inset) with similar findings using absolute 
fluorescence (Control: 50.15 ± 7.21 a.u, 49°C: 16.67 ± 4.44 a.u, p<0.05, Figure 11e). No 
difference was found after 49⁰C treatment for the 25kDa, 44kDa and  60kDa bands (25kDa 
Control: 0.67 ± 0.12 a.u, 25kDa 49⁰C: 0.91 ± 0.35 a.u, 44kDa Control: 4.29 ± 0.4 a.u, 44kDa 
49⁰C: 4.73 ± 1.49 a.u, 60kDa Control: 0.6 ± 0.07 a.u, 60kDa 49⁰C: 1.02 ± 0.24 a.u, Figure 11b, 
11c and 11d, respectively). 
Using the plate approach for 49⁰C treated samples, we found that heated samples had 
significantly lower fluorescence compared to controls (Control: 2.56 ± 0.38 a.u, 49⁰C: 0.58 ± 
0.22 a.u, p<0.05, Figure 12). 
The GSH content of 49°C treated samples did not differ from control (Control 18.41 ± 
4.07 µmol/g, 49°C: 18.71 ± 2.51 µmol/g, Figure 13a). GSSG content was significantly greater in 
the heat treated group (Control: 1.31± 1.68 µmol/g, 49°C: 2.15 ± 0.17 µmol/g, p<0.05, Figure 
13b) while the ratio of GSH/GSSG showed a significant decrease after heating at 49°C (Control: 
13.39 ± 1.68, 49°C: 8.35 ± 0.63, p<0.05, Figure 13c).  
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Figure 11. Effects of 49°C heat treatment on fluorescence using in-gel approach.  
Using the direct redox method, 49⁰C significantly decreased fluorescence between 
25-100kDa for both absolute (e) and relative (e. inset) values. This difference was 
removed when bands at 25kDa, 44kDa and 60kDa (b, c and d, respectively) were 
considered. Signals from these bands in the heated condition trended higher than 
controls. DIGE results showed no difference after heating with absolute fluorescence 
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densitometry (e) however there was a significant decrease after heating relative to 
control fluorescence (e. inset). All other panels showed similar statistics with 
absolute and normalized values (data not shown). Results represented as mean ± 
SEM. * indicates significantly different from control, p<0.05. N=5-6. 
 
 
Figure 12. Effects of 49°C heat treatment on fluorescence using in-well plate 
assay. Samples exposed to 49°C temperatures showed a decrease in fluorescence 
compared to control. Results represented as mean ± SEM. * indicates significantly 
different from control, p<0.05. N=5. 
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Figure 13. Effects of 49°C heat treatment on GSH, GSSG and GSH/GSSG ratio. 
Samples exposed to 49°C temperatures showed no significant change in GSH content 
(a) while GSSG content significantly increased (b) and GSH/GSSG ratio 
significantly decreased (c). Results represented as mean ± SEM. * indicates 
significantly different from control, p<0.05. N=4-5. 
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40⁰C Treatment 
 In contrast to 49°C incubations, 40°C incubations showed no significant difference in 
fluorescence with the in-gel assay using our direct method (Control: 37.21 ± 0.89 a.u, 40°C: 
31.23 ± 11.52 a.u, Figure 14e) with the same statistical findings when normalized to control 
(Figure 14e inset). Similarly, no difference was found for the 25kDa, 44kDa and 60kDa bands 
(25kDa Control: 1.81 ± 0.29 a.u, 25kDa 40⁰C: 2.19 ± 0.64 a.u, 44kDa Control: 3.96 ± 0.3 a.u, 
44kDa 40⁰C: 4.13 ± 1.22 a.u, 60kDa Control: 0.71 ± 0.04 a.u, 60kDa 40⁰C: 0.77 ± 0.15 a.u, 
insets of Figure 14b, 14c and 14d, respectively). 
 While the DIGE results from 25-100kDa showed no significance when considering 
absolute values (Control: 11.23 ± 4.18 a.u, 40°C: 1.41 ± 0.48 a.u, Figure 14e), there was a 
significant decrease in fluorescence using this method when considering values normalized to 
control (40⁰C: 0.17 ± 0.05 a.u, p<0.05, Figure 11e inset). Differences were also found after 40⁰C 
treatment for the 25kDa, 44kDa and  60kDa bands (25kDa Control: 0.62 ± 0.22 a.u, 25kDa 40⁰C: 
0.05 ± 0.01 a.u, 44kDa Control: 1.7 ± 0.44 a.u, 44kDa 40⁰C: 0.19 ± 0.05 a.u, 60kDa Control: 
0.42 ± 0.11 a.u, 60kDa 40⁰C: 0.09 ± 0.02 a.u, Figure 14b, 14c and 14d, respectively). 
The in-well approach showed no difference compared to control after heating to 40⁰C 
(Control: 2.13 ± 0.32 a.u, 40°C: 1.92 ± 0.22 a.u, Figure 15).  
These conditions also brought about a significant decrease in GSH content (Control: 
16.32 ± 0.41 µmol/g, 40°C: 10.15 ± 1.25 µmol/g, p<0.05, Figure 16a). GSSG showed no 
significant change (Control: 0.66 ± 0.02 µmol/g, 40°C: 0.74 ± 0.04 µmol/g, Figure 16b) while 
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the GSH/GSSG ratio showed a significant decrease (Control: 24.86 ± 0.38, 40°C: 13.53 ± 1.09, 
p<0.05, Figure 16c).  
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Figure 14. Effects of 40°C heat treatment on fluorescence using in-gel assay. 
Representative image (a). Using the direct redox method, samples exposed to 40°C 
temperatures showed no significant change in fluorescence when measuring 25kDa 
(b), 44kDa (c), 60kDa (d) bands or lane measurements from 25-100kDa (e). The 
same was found for DIGE results for the individual bands. Our DIGE results at the 
42 
 
25-100kDa range showed no significance after heat treatment when considering 
absolute fluorescence densitometry (e) however a significantly lower signal was 
found when normalized to control (e. inset). All other panels showed the same 
statistical findings with absolute and normalized data (data not shown). Results 
represented as mean ± SEM. * indicates significantly different from control, p<0.05. 
N=5-6.Results represented as mean ± SEM. * indicates significantly different from 
control, p<0.05. N=4-6. 
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Figure 15. Effects of 40°C heat treatment on fluorescence in-well plate assay. 
Samples exposed to 40°C temperatures showed no significant change in fluorescence 
when measured in gel. Results represented as mean ± SEM. N=6. 
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Figure 16. Effects of 40°C heat treatment on GSH, GSSG and GSH/GSSG ratio. 
Samples exposed to 40°C temperatures showed a significant decrease in GSH content 
(a) while GSSG content remained unchanged (b). The GSH/GSSG ratio significantly 
decreased (c). Results represented as mean ± SEM. * indicates significantly different 
from control, p<0.05. N=5-6. 
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Effects of 40⁰C and 49⁰C Treatments on Carbonylation 
 There was no significant change in protein carbonyl products after 40°C (Control: 31.92 
± 3.26 a.u, 40°C: 36.21 ± 3.83 a.u, Figure 17a).  
On the other hand, the 49⁰C treated group showed a significant increase in carbonylation 
(Control: 33.1 ± 4.13 a.u, 49°C: 93.87 ± 10.23 a.u, p<0.05, Figure 17b).   
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Figure 17. Effects of 40°C and 49°C treatment on protein carbonylation. Heat 
treatment at 40⁰C did not show a change in protein carbonylation compared to 
control (a). 49°C treatment significantly increased the level of carbonylation (b). 
Results represented as mean ± SEM. * indicates significantly different from control, 
p<0.05. N=4-6. 
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Chapter 6: Discussion 
Our aim in this study was to determine whether IRDye800CW Maleimide can accurately 
detect reduced thiols in cardiac tissue lysates and whole cells using simplified methodologies 
such as SDS-PAGE and in-well plate assays. In order to do this we first had to establish the 
appropriate conditions required for the use of IRDye800CW Maleimide. These optimizations are 
listed in section 6H below. We employed a number of treatments to alter the redox state of 
lysates in order to confirm the dye’s efficacy at accurately detecting reduced thiols through 
multiple avenues.  
 
6A - Desalting leads to increased fluorescent signal with IRDye800CW Maleimide 
Early into our optimization for this assay we noticed that desalting samples through Zeba 
desalting columns prior to the addition of any reagents led to a large increase in IRDye800CW 
Maleimide’s fluorescence using in-gel and in-well plate assays in both CHAPS and TRIS buffer 
(Figure 4). We continued our experiments using TRIS since a number of experiments comparing 
CHAPS and TRIS showed the latter to be more consistent throughout our dye experiments (data 
not shown).  We suspected that endogenous GSH in tissue could be interfering with our dye’s 
ability to bind to protein thiols due to the abundance of GSH in cells (mM range)
85
. Furthermore, 
we suspected that the Zeba columns, which remove substances below 7000Da were effectively 
removing endogenous GSH (307Da) thereby allowing more of the dye to bind to the remaining 
protein thiols leading to an increase in fluorescence. To test this hypothesis we measured GSH 
content in both non-desalted (ND) and desalted (D) samples. As shown in figure 5, desalting led 
to a small yet significant drop in GSH content in cardiac tissue lysates. Admittedly, we expected 
a much larger drop in GSH content after desalting yet our current results suggest that GSH is a 
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partial contributor to the dye interference we observed and that other factors, such as free 
cysteine and coenzyme A, may be interfering with dye binding prior to desalting due to the 
presence of thiols in these molecules.  
 
6B - Oxidizing and reducing agents may interfere with IRDye800CW Maleimide 
 Next we determined whether our chosen reagents for oxidation (H2O2+NaI) and reduction 
(TCEP) would have an interaction with IRDye800CW Maleimide and our results indicate that 
the dye’s fluorescence dropped in the presence of these reagents (Figure 6). It is important to 
note that the quenching experiment was done in-well and did not undergo the same steps as 
homogenates. Mainly, when homogenates have been treated with their respective reagents, they 
undergo a desalting step in order to remove excess H2O2+NaI and TCEP, while in the quenching 
experiment dye was added directly to solutions containing their respective reagents. Thus, while 
the quenching data suggests a decrease in fluorescence in the presence of the reagents, we would 
expect even less of an interaction after desalting as is done with homogenates. However, we have 
not yet eliminated the possibility that residual reagents may be left over after desalting which 
could be interfering at some level with our dye.  
 
6C - Effects of Reducing and Oxidizing samples on IRDye800CW Maleimide fluorescence 
 Our first method for manipulating the redox state of our lysates involved the use of 
H2O2+NaI as our oxidizing agent and TCEP as our reducing agent. As seen in Figure 7, the 
oxidized group had a much lower signal than control. For our reduced group we expected to find 
a greater signal than control. Interestingly, however, our reduced condition in gel also 
significantly lowered fluorescence when normalized to control while absolute values showed a 
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trending, albeit non-significant decrease. While this finding may partly be due to dye quenching 
caused by residual TCEP left after desalting, we questioned whether TCEP was an effective 
reducing agent. At the same time, we wondered whether the physiological state of most 
proteomic cysteines exist in the reduced state, thereby preventing our signal to increase above 
control levels. In order to guide our understanding towards these questions we needed to develop 
a way to test the efficacy of TCEP as a reducing agent.  
 
6D - TCEP returns fluorescence of Oxidized samples to Control Levels 
By incorporating a ‘rescue’ condition in which we subsequently oxidized and reduced the 
sample, we would be able to better determine the reducing power of TCEP. Our in-gel data 
shows that following oxidation, TCEP was able to return fluorescence back to control levels 
(Figure 8a) even while the reduced condition continued to show a drop in signal when 
normalized to control (Figure 8b, inset) although no significant decrease was found when 
considering absolute fluorescence (Figure 8b). Our plate data shows similar results with the 
oxidized and rescue groups (Figure 9a) but what is important to note with this set of data is that 
the reduced condition shows a significant increase in signal compared to control (Figure 9b) 
while the in-gel data shows a trending decrease after reduction (Figure 8b). Similarly, the rescue 
condition in plate also trends towards an increase in signal while the in-gel rescue condition is 
slightly lower than control. We have not yet determined the exact cause of this discrepancy 
between gel and plate in the TCEP treated samples. One possible cause is that the in-gel method 
separates proteins based on molecular weight and has an upper limit of 250kDa based on western 
protocol. Furthermore, our in-gel analysis covers the range of 25-100kDa. While this allows us to 
discriminate between proteins and their redox states within that range, it removes information 
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beyond these upper and lower limits. It is possible that the plate data incorporates more redox 
sensitive proteins (even with the same amount of total protein as the gels) leading to a greater 
signal compared to the in-gel fluorescence. 
What is interesting to notice as well with our TCEP experiments is that not all bands 
showed greater fluorescence compared to control. The fluorescence of the 37kDa band, for 
example, decreases in TCEP-treated samples compared to control. It is not yet clear why this 
occurs however it may suggest that not all proteins share the same ability to be reduced. It is 
possible that certain proteins that exist in a reduced state are close to the reductive limit of the 
protein such that any further reduction will lead to ‘reductive stress’. Indeed, it has been shown 
that cardiac mitochondria increase the rate of ROS production in states of reductive stress
86
 and 
certain proteins may therefore be more susceptible to oxidation by ROS produced in this fashion. 
In order to confirm the validity of our findings using the IRDye800CW Maleimide using 
both the in-gel and plate approach, we determined the level of GSH, GSSG and the ratio of 
GSH/GSSG (Figure 10). Control and reduced groups all showed similar GSH content (Figure 10, 
a2) with similar findings in GSSG content (Figure 10, b2) and the GSH:GSSG ratio (Figure 10, 
c2). The increase in GSSG content for the oxidized group suggests a higher level of oxidation 
occurred with this treatment while the other conditions showed no difference in GSSG content 
(Figure 10, b1). All conditions showed no differences in GSH content (Figure 10, a1) and the 
GSH:GSSG ratio (Figure 10, c1). The observations made with GSSG content in these samples 
present a case where the dye could be more predictive of GSSG content rather than GSH content. 
They also indicate that the IRDye800CW Maleimide closely follows the GSSG and GSH/GSSG 
ratio patterns measured with HPLC suggesting that it may be used as a strong predictor of 
cellular redox state. 
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6E - 49⁰C heat treatment lowers IRDye800CW Maleimide fluorescence  
 To follow up with our chemically-induced changes to redox state of lysates, we moved 
forward by manipulating redox states using heat since this is known to increase markers of 
oxidative stress such as thiobarbituric acid reactive substances (TBARS)
84
 and DNA 
degredation
87
. It has previously been shown that 42⁰C temperatures in rat tissue showed a time-
dependent increase in ROS production
88
. Furthermore, rats with core temperatures of 42⁰C 
showed an increase in markers of oxidative stress which subsided after a given amount of 
recovery time
87
. Given these findings, we were interested using heat as one of our models for 
altering cellular redox states and we chose 49⁰C to ensure sufficient oxidation in cells, potentially 
leading to irreversible oxidative modifications such as carbonylation. As expected, we saw a 
significant decrease in fluorescence after heat-exposure, suggesting that proteins have been 
oxidized and that the dye was accurately able to capture these differences in-gel at the 25-
100kDa range using our direct method (Figure 11e) and using the in-well approach (Figure 12).  
 While we noticed a drop in overall fluorescence after heating, specific bands of the 
proteome were also assessed to determine their influence on the overall 25-100kDa fluorescence. 
Our attention shifted to the bands located at 25kDa (Figure 11b), 44kDa (Figure 11c) and 60kDa 
(Figure 11d) since these regions showed a trending increase in fluorescence after 49⁰C heat 
treatment. The reasons for these observations have yet to be determined however we speculate 
that spatial separation and localization of specific redox sensitive proteins may play a role. 
Indeed, it has been found that different cysteine residues are localized such that they possess a 
range of pKa values leading to a range of reactivity with oxidizing and reducing environments
2
. 
This notion of compartmentalization also provides a means of specificity for cysteines to react 
with ROS/RNS since there is no direct receptor for the molecules. 
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We were interested in comparing our method to a previously published approach used by 
Requejo et al.
79
 in which samples were first treated with N-ethylmaleimide (NEM) to irreversibly 
block all reduced thiols. This leaves all reversibly oxidized proteins untouched until a reducing 
compound is added (such as TCEP). The newly reduced thiols are then labeled with a maleimide-
based dye similar to IRDye800CW and the measured fluorescence densitometry represents 
proteins that were initially in the oxidized state. It has been suggested that this ‘difference in gel 
electrophoresis’ (DIGE) method of indirectly measuring oxidized proteins is more sensitive than 
measuring reduced thiols
79
. However, a limitation to this DIGE method is that it can only provide 
information on reversible thiol modifications whereas the present method would in theory reflect 
all forms of oxidation. While this may be an important consideration for particular research 
questions, it does not allow researchers to investigate questions regarding total redox states. In 
order to confirm which method would provide more sensitivity with respect to proteomic redox 
states we compared our direct method with the DIGE method for our heat experiments. In doing 
so, we expected to see a drop in signal after heating using the direct method, while the DIGE 
method would show the opposite with heat treatment increasing fluorescence. As seen from the 
results in panel e of Figure 11, the DIGE method did not work in our hands since fluorescence of 
the 25-100kDa range dropped after oxidation with 49⁰C. We suspected that this may be caused 
by irreversible oxidation caused by the high temperature. To test this possibility, we proceeded to 
compare the two methods using 40⁰C heat (discussed below) which is considered to be high 
enough to cause oxidation but low enough to it reversible
87
. 
As a tool for validating IRDye800CW Maleimide we again measured GSH and GSSG 
content to see if a relationship existed between fluorescence and cellular redox state after 49⁰C 
incubations. While this heat treatment did not change GSH content (Figure 13a), GSSG content 
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showed a significant increase (Figure 13b) with a concomitant decrease in the GSH/GSSG ratio 
(Figure 13c). This increase in GSSG may be attributed to an increase in glutathionylated proteins 
as a result of high heat which is known to create an oxidative environment
89
. Nevertheless, this 
data suggests that the dye may be used to determine GSSG content in homogenates. 
 
6F - 40⁰C heat treatment has no significant effect on IRDye800CW Maleimide fluorescence 
 By lowering the temperature of our oxidized group to 40⁰C, we expected to find smaller 
differences between control and heated samples using our direct method since this temperature 
leads to less oxidative stress compared to 49⁰C87. Indeed, our 25-100kDa in-gel (Figure 14e) and 
the plate assay (Figure 15) showed no significant difference between control and heated samples 
suggesting that oxidation was minimal and that IRDye800CW Maleimide fluorescence 
corresponds to the level of reduced proteins. In line with our 49⁰C results, the three specified 
bands at 25, 44 and 60kDa showed a trending increase in fluorescence after heating. As discussed 
above, one possibility for this might be spatially-determined specificity and 
compartmentalization. 
 We dropped the temperature of our heated group to 40⁰C in-part to determine whether 
our failed attempts at the DIGE method had to do with irreversible oxidation caused by 49⁰C 
heat. Figure 14 DIGE results show that this issue was not resolved with this change since the 
oxidized samples continued to show decreased fluorescence compared to control as we expect to 
see the opposite with this method. It is still unclear why the DIGE method has failed in our hands 
however one consideration is the dyes used for the experiments. We have optimized our direct 
protocol for use with the IRDye800CW Maleimide and have validated this dye through a number 
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of methods presented in this paper however Requejo et al. used a Cy3 and Cy5 fluorophores in 
their DIGE methods
79
.  
 GSH content (Figure 16a) and GSH/GSSG ratios (Figure 16c) showed a significant drop 
after 40⁰C treatment while GSSG content showed a trending yet insignificant increase (Figure 
16b). Once again this closely follows the data observed with direct in-gel whole-lane 
fluorescence (Figure 14e) and plate fluorescence (Figure 15) for the 40⁰C treatment presenting 
yet another case where IRDye800CW Maleimide fluorescence is related to GSSG content. 
 
6G - 49⁰C heat significantly increases protein carbonylation while 40⁰C does not 
 In order to address whether our selected temperatures were causing reversible or 
irreversible oxidation, we included an experiment to look at carbonylation of proteins since this 
is a form of irreversible protein oxidation. As expected we found that there was a significant 
increase in carbonylated proteins with 49⁰C (Figure 17b) while 40⁰C heat led to no change 
relative to control (Figure 17a). IRDye800CW Maleimide fluorescence is very closely related to 
protein carbonylation such that wherever a significant increase in carbonyl products occurs 
(49⁰C, Figure 17b) there is a significant decrease in dye fluorescence in-gel (Figure 11e) and in 
plate (Figure 12). The same relationship holds true in the 40⁰C group where no significance was 
observed in carbonylation (Figure 17a), in-gel fluorescence (Figure 14e) and in plate (Figure 15). 
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Chapter 7: Conclusions and Future Directions 
7A - Conclusions 
 This study was aimed at validating the IRDye800CW Maleimide as a useful tool for 
accurately detecting the redox state of lysates. While there are currently highly sensitive methods 
available, such as mass spectrometry and HPLC, access to these instruments may be limited to 
some researchers due to their high cost and technical expertise. Given these accessibility barriers, 
these labs may not have the resources or the training required to use these instruments but instead 
possess laboratory infrastructure for western blotting or microplate assays. As such, it is 
important for researchers to have an affordable and reliable option to directly detect protein 
redox states using a method that can be incorporated into commonly used assays such as SDS-
PAGE and in-well assays. Here, we have taken multiple approaches to test whether the changes 
observed in the dye’s fluorescence match results of redox state measured through GSH and 
GSSG content as well as protein carbonylation. We can conclude, based on the evidence 
presented in this study, that the IRDye800CW Maleimide does accurately represent the redox 
state in homogenates. Our target audience is the researchers who are interested in analyzing 
redox states of samples but whose primary focus is not redox bioenergetics. This method offers a 
simplified and affordable approach for such labs to accurately detect the redox state of proteins in 
samples. While the IRDye800CW Maleimide does not provide information regarding the specific 
form of oxidative modification that has occurred, this limitation presents one of its greatest 
strengths in that it accurately captures all forms of oxidation and reduction in a given sample 
providing researchers with a wealth of information related to redox states. 
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7B – Future Directions 
 The data we have presented thus far all involves a form of in vitro modification of redox 
states, whether through treating homogenates with different reagents or via exposure to heat. 
Since many researchers are interested in looking at in-vivo models, we would be interested in 
testing IRDye800CW Maleimide under such conditions that can bring about change in cellular 
redox states. One potential avenue of doing this is by looking at tissue that has gone through an 
acute bout of exercise or dietary influences since these are known to increase oxidation
98
. Certain 
disease conditions, such as muscular dystrophy, Alzheimer’s and Parkinson’s,  have also shown 
to have elevated levels of ROS and oxidative stress
99–101
. 
 We have demonstrated that desalting homogenates prior to labeling with the dye greatly 
enhances our signal. While we show that endogenous glutathione plays a role in this finding, it 
does not appear to be the only factor. It would be useful to determine the levels of other thiol-
containing compounds, such as free cysteines and coenzyme A, after desalting. Furthermore, it 
would be useful to determine whether or not the desalting columns are completely removing our 
reagents since we have shown that there is a quenching effect between the dye and the reagents. 
The hypothesis that not all reagents are being removed by desalting would be consistent with our 
findings in Figure 8 where our TCEP-treated samples show lower fluorescence than control. If 
this is the case then our current findings with IRDye800CW Maleimide in both oxidized and 
reduced samples could be an underestimation of what is really occurring. Therefore it is 
important for us to determine the levels of H2O2+NaI and TCEP after desalting. 
 Finally, to compare the sensitivities of the direct detection of thiols versus the indirect 
DIGE method, we must resolve our results with the DIGE method. A potential avenue to 
consider is the use of dyes. Our direct method incorporates the IRDye800CW Maleimide and this 
is the dye we used when attempting the DIGE method. However Requejo et al used the Cy3 and 
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Cy5. Although all of these dyes have similar properties (i.e. being maleimides) they may still 
contain differences that require consideration when used in homogenates. Future studies 
comparing these two methods may need to consider these differences. 
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Appendix A – Optimization Process for IRDye800CW Maleimide 
 Prior to beginning our experiments with IRDye800CW Maleimide, we intended to mimic 
the protocol presented by Sloan et al. in which they used PBS (pH 7.5) with 5mM DTT as their 
reducing agent and 5mM H2O2 as their oxidizing agent
72,90
. We did this in order to determine 
whether we would obtain similar results before proceeding with other forms of validation. In our 
attempts at this method, we were unable to repeat the findings obtained from these two studies. 
As previously shown in our results, one of the key steps that had to be incorporated to our assay 
was desalting samples prior to dye labeling (Figure 4 and 5). Once this first problem was 
addressed, we were able to continue our troubleshooting process. 
 
A1. Assay Buffer 
Following previous protocols
90,91
 our initial redox assays were done in PBS, however as 
described below in our optimizing procedures, we switched from DTT to TCEP as our reducing 
agent, which required a buffer change as well since TCEP is considered to be less stable in 
phosphate buffers at neutral pH
92
. We attempted the assay in both CHAPS and Tris buffers due 
to their low cost and ease of preparation and we found that both buffers yielded similar results, 
although fluorescence seemed to be greater and more consistent in Tris for all conditions 
compared to CHAPS (data not shown). 
 
A2. Incubation Conditions 
As seen in Supplemental Figure 1 in Appendix B, we obtained results that were opposite 
from what we expected such that the DTT samples were less fluorescent than control and H2O2 
samples were more fluorescent than control. We speculated that the reasons why DTT and H2O2-
67 
 
treated samples did not match previously reported findings might have to do with our incubation 
parameters. We had started by incubating samples for 1 hour on a rocker at room temperature 
however this did not resolve our issues (data not shown). We speculated that the reaction 
between thiols and our reagents was not occurring fast enough therefore we decided to incubate 
for 1 hour at 37⁰C in an attempt to speed up the reaction of thiol groups with DTT and H2O2 but 
this did not improve our signal. Once we decreased the incubation period to 30 minutes at room 
temperature we began to notice improvements in our H2O2-treated samples which showed less 
fluorescence than previous experiments. In accordance with these findings, it has been suggested 
that hydrogen peroxide is an unstable compound that is both temperature and light sensitive
93
. 
Given our findings with incubation time and temperature, it may be possible that 1 hour exposure 
of H2O2 to room temperature or higher is enough to degrade the compound and prevent effective 
oxidation of thiols in homogenate. Although these incubation parameters improved our H2O2 
signals compared to previous experiments, results using these incubation times still showed 
greater fluorescence with H2O2 relative to controls (data not shown). Therefore, we looked to 
other solutions for troubleshooting our protocol before determining our ideal incubation 
parameters. 
 
A3. DTT and H2O2 
In order to address our low DTT signal and high H2O2 signal we questioned whether 
these compounds were effective enough to cause changes in thiol groups in homogenates. DTT is 
a commonly used reducing agent but it has been suggested that DTT may actually be a poor 
reducing agent due to its low reactivity at neutral pH
94
 which is near the effective pH range of the 
IRdye800CW-Maleimide (6.5-7.5). Because of its pKa value, the thiolate anions of DTT are 
68 
 
protonated and therefore unreactive at neutral pH, with only 1% of its thiols reportedly being 
reactive
94
. Consistent with this finding, our initial results with DTT demonstrate that at a pH of 
7.5, DTT incubations were not effective at increasing fluorescent intensity as compared to 
untreated samples (Supplemental Figure 1, Appendix B). Given the reports and our findings on 
DTT, we began implementing tris (2-carboxyethyl) phosphine (TCEP) as a reducing agent. 
TCEP is another commonly used reducing agent which has been reported to show stability across 
a wide pH of 1.5-8.5
95,96
. After incorporating TCEP into our samples we found IRDye800CW-
Maleimide’s absolute fluorescence values showed no difference while normalized values showed 
a significant decrease in fluorescence (Figure 7). Given our observations with the effective 
rescue condition of TCEP (Figure 8), we proceeded with this reducing agent for the remainder of 
our optimization. 
 We suspected that H2O2 was not working because it lacked sufficient stability to react 
with thiols in the 30 minutes we allowed it to incubate in our samples. As such, we decided to 
add sodium iodide to our H2O2 solution since this is known to be a catalyst in the reaction 
between H2O2 and thiols
97
. By incorporating sodium iodide we found that fluorescence dropped 
well below that of controls and the results from our quenching suggest that this was largely a 
result of protein thiol oxidation as opposed to fluorescence interference (Figure 6). The 
mechanism of this catalytic reaction with sodium iodide still remains unclear however it appears 
that iodide may mediate electron transfer between thiols and H2O2
97
.  
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Appendix B: Supplemental figures 
 
Supplemental Figure 1.  Representative image of redox western on mouse cardiac 
lysate in phosphate buffer (pH 7.5) with samples incubated with 5mM DTT and 
5mMH2O2.  100nM IRDye per sample. 
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Appendix C: Buffers 
Tris buffer 
Chemical Final Concentration (mM) 
Tris 144.5 
MgCl2 1.44 
*pH to 7.1 at 4⁰C 
Chaps buffer 
Chemical Final Concentration 
NaCl 120mM 
NaF 50mM 
HEPES 40mM 
B-glycerophosphate 10mM 
NaHP2O7•H2O pyrophosphate 10mM 
CHAPS 0.30% 
*pH to 7.5 
Heat treatment buffer 
Chemical Final Concentration (mM) 
NaCl 145 
Hepes 10 
KCl 3 
CaCl2 2.5 
*pH to 7.4 
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Tris BSAN buffer (for HPLC measures) 
Chemical Final Concentration (mM) 
Tris 50 
Boric Acid 20 
Acivicin 20 
NEM 5 
L-Serine 2 
 
Appendix D: Homogenization protocol 
1. Place muscle in metal dish filled with liquid nitrogen 
2. Using pre chilled spatula chip piece of muscle of desired size 
3. Using pre chilled forceps quickly place muscle on scale to get rough weight (do not wait 
for steady weight). While weighing, place forceps back in liquid nitrogen to remain cool 
4. After getting weight, place muscle back in liquid nitrogen storage dewer until all samples 
have been weighed 
5. Using the following dilution protocol place muscle in desired volume of homogenization 
buffer that contains: 
1:100 Phosphatase Inhibitors 2 and 3 
1:200 Protease Inhibitors 
6. Dilutions:  300uL CHAPS buffer/30-40mg of muscle 
7. Fill 50mL beaker with ice and place eppendorf with muscle securely in ice 
8. Homogenize using tapered pestle for 2x30 seconds 
9. Centrifuge at 13,500g for 10 minutes at 4C 
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Appendix E: Final protocol for treatment with TCEP and H2O2 
1. Weigh 40 mg of cardiac muscle 
2. Put the tissue in 1.5 ml tube and 0.3 ml ice cold Tris buffer containing protease inhibitors 
3. Mince tissue with fine scissors and homogenize on ice for 2 x 30s. Repeat for another 30s 
if necessary. 
4. Spin down for 10 min at 13,500 rpm 
5. Collect supernatants and run each sample through 2 successive desalting Zeba columns to 
remove endogenous glutathione (and other dye-interfering factors) 
6. Determine protein concentration using BCA assay 
7. Dilute samples to 4.167mg/ml in 200µl total volume 
8. Add 1mM TCEP and 5mM H2O2+NaI to their respective samples 
9. Incubate all samples together on a rocking platform for 5 minutes at room temperature 
10. Run each sample again through 2 successive desalting Zeba columns to remove excess 
reagents 
11. Determine protein concentration using reducing-agent compatible BCA assay 
12. Dilute samples to 1mg/ml and label with 400nM IRDye800CW Maleimide 
13. Incubate overnight 
14. Next day remove excess dye by spinning through 2 successive desalting Zeba columns 
15. Determine protein concentration and proceed with western blotting protocol 
Appendix F: BCA protein assay 
 
1. Create protein standards by diluting BSA in homogenization buffer 
2. Standards (BSA): 
0 mg/mL (buffer) 
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0.0625 mg/mL 
0.125 mg/mL 
0.25 mg/mL 
0.50 mg/mL 
0.75mg/mL 
1.00 mg/mL 
3. Dilute 5µl  of each sample in 45µl of homogenization buffer 
4. Using a 96-well plate load 10µl in triplicates each standard and each sample 
5. Add 190µl of working reagent (50:1 Solution A:SolutionB) into each well of sample 
6. Heat in over for 30 minutes at 37C 
 
Reducing agent compatible (RAC) BCA assay 
1. Prepare a sample (without protein) containing reducing agent at the same concentration as 
experimental samples 
2. Repeat steps 1-3 above for all samples 
3. Using a 96-well plate load 9µl of each standard and sample in triplicates 
4. Add 4µl of Compatibility Reagent (reconstitution buffer + compatibility reagent) to each 
sample in each well 
5. Incubate plate for 15 minutes at 37⁰C 
6. Add 260µl of working reagent to each well and incubate for 30 minutes at 37⁰C 
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Appendix G: Western blotting protocol 
Gel preparation 
 
1. In 50mL falcon tubes make running gel and stacking gel (1 column makes 2 gels) *DO 
NOT ADD TEMED UNTIL READY TO LOAD 
2. Take 1 short plate and one spacer plate and clean both sides of glass with methanol and 
kimwipe 
3. Place clean short plate on top of spacer place and place both in mounting apparatus, 
ensuring the edge of the plates are lined up against the bench top 
4. Place plates in apparatus on foam piece in gel stand 
5. Place 3 transfer pipettes and falcon tube with methanol close to gel stand 
6. Add TEMED to running gel and invert falcon tube 1-2 times 
 Stacking Running 
5% 6% 8% 10% 12% 
dH2O 6.8 ml 11.4 10.6 ml 9.4 ml 8 ml 6.7 ml 
1.5M Tris-Base, pH 8.8 *** 5 ml 5 ml 5 ml 5 ml 5 ml 
1M Tris-HCl, pH 6.8 1.25 ml *** *** *** *** *** 
30 % Acrylamide 1.70 ml 3.4 ml 4 ml 5.3 ml 6.7 ml 8 ml 
10 % SDS 100 μl 200 μl 200 μl 200 μl 200 μl 200 μl 
       
10 % APS 100 μl 200 μl 200 μl 200 μl 200 μl 200 μl 
Temed 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl 
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7. Using transfer pipette, fill space between glass plates with running gel until solution 
reaches the top of the green doors 
8. Using new transfer pipette add methanol to top of plate to create an even line along the 
top of the gel removing any bubbles 
9. Let sit until remaining running gel has set in the flacon tube 
10. Once gel has hardened, invert gel to remove any excess methanol 
11. Add TEMED to stacking gel and mix 
12. Using transfer pipette, add stacking gel to top of glass plates, use methanol transfer 
pipette to remove any bubbles 
13. Add comb to top of gel and allow to set 
14. Prepare diluted samples by combining sample, water and Laemmeli’s buffer + 2-
mercaptoehtanol (100 μl 2-mer: 900 μl Lam) 
15. Spin down samples for 5 seconds 
16. Make 1X running buffer in 1000mL graduated cylinder 
17. Remove combs from gels and place gels in gasket 
18. Place gasket with gels in tank and add 1X running buffer until it fills the top of gasket and 
tank 
19. Load wells with desired concentration of samples 
20. Run for desired time (40-75 minutes) at 160mV (or desired voltage) and protect from 
light 
21. When run is complete, carefully remove gel, rinse with TBST to remove small bubbles 
from surface 
22. Detect using LiCOR Infrared Imager 
 
